Tags

Type your tag names separated by a space and hit enter

Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
Br J Haematol. 2020 07; 190(2):e73-e76.BJ

Authors+Show Affiliations

Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.Division of Infectious Diseases, Icahn School of Medicine at Mount Sinaii, New York, NY, USA.Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Pub Type(s)

Case Reports
Letter

Language

eng

PubMed ID

32433778

Citation

Thibaud, Santiago, et al. "Protective Role of Bruton Tyrosine Kinase Inhibitors in Patients With Chronic Lymphocytic Leukaemia and COVID-19." British Journal of Haematology, vol. 190, no. 2, 2020, pp. e73-e76.
Thibaud S, Tremblay D, Bhalla S, et al. Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19. Br J Haematol. 2020;190(2):e73-e76.
Thibaud, S., Tremblay, D., Bhalla, S., Zimmerman, B., Sigel, K., & Gabrilove, J. (2020). Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19. British Journal of Haematology, 190(2), e73-e76. https://doi.org/10.1111/bjh.16863
Thibaud S, et al. Protective Role of Bruton Tyrosine Kinase Inhibitors in Patients With Chronic Lymphocytic Leukaemia and COVID-19. Br J Haematol. 2020;190(2):e73-e76. PubMed PMID: 32433778.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19. AU - Thibaud,Santiago, AU - Tremblay,Douglas, AU - Bhalla,Sheena, AU - Zimmerman,Brittney, AU - Sigel,Keith, AU - Gabrilove,Janice, Y1 - 2020/06/04/ PY - 2020/05/14/received PY - 2020/05/17/accepted PY - 2020/5/21/pubmed PY - 2020/7/28/medline PY - 2020/5/21/entrez KW - BTK inhibitors KW - CLL KW - COVID-19 SP - e73 EP - e76 JF - British journal of haematology JO - Br. J. Haematol. VL - 190 IS - 2 SN - 1365-2141 UR - https://www.unboundmedicine.com/medline/citation/32433778/Protective_role_of_Bruton_tyrosine_kinase_inhibitors_in_patients_with_chronic_lymphocytic_leukaemia_and_COVID_19_ L2 - https://doi.org/10.1111/bjh.16863 DB - PRIME DP - Unbound Medicine ER -